Funded Tech Companies
VintaBio
Based in Philadelphia, VintaBio raised its funding from Decheng Capital.
Company Overview
Company Name
VintaBio
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
4050 S. 26th St 160/200
Philadelphia, PA 19112
USA
Philadelphia, PA 19112
USA
Phone
Website
Email Address
Company Background Information
Overview
VintaBio's development and manufacturing team has over a century of experience in the cell and gene therapy space and its members have played key roles in the development of the most advanced therapies on the market today. Located in the historic Navy Yards of Philadelphia -- the epicenter of cell and gene therapy innovation -- VintaBio specializes in developing and manufacturing consistent, high-quality viral vectors, a vital and currently underserved area of CGT development. The company was founded by Junwei Sun and Dr. Shangzhen Zhou, who led development of the AAV vectors behind the first two FDA-approved gene therapies, as well as the lentiviral vector for the first FDA-approved cell therapy. VintaBio has raised $64 million in venture funding, which has been used to develop a brand new 22,500 square foot facility in Philadelphia created specifically to facilitate efficient cell and gene therapy manufacturing.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/11/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Radspinner
Chief Operating Officer
Junwei Zhang
Co-Founder
Shangzhen Zhou
Company Investors
Browse more funded tech companies:
Share this article
About Our VC Funding Database
The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs